Misha Petkevich - 28 Oct 2021 Form 4 Insider Report for CohBar, Inc.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
01 Nov 2021, 09:15:25 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey F. Biunno, Attorney-in-fact for Misha Petkevich

Key filing fact

Misha Petkevich filed Form 4 for CohBar, Inc. on 01 Nov 2021.

Key facts

  • This page summarizes Misha Petkevich's Form 4 filing for CohBar, Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Nov 2021, 09:15.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$96,175.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CWBR transaction

Common Stock

Purchase

Transaction value
$96,175
Shares
+167,000
Change %
+69%
Price
$0.5759*
Shares after
407,609
Date
28 Oct 2021
Ownership
See Footnote
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person is a General Partner of V2M Life Sciences L.P. ("V2M"), and has sole voting and dispositive power over the securities held by V2M. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .